Article
In this OncLive video, Jatin J. Shah, MD, assistant professor in lymphoma/myeloma in the Division of Cancer Medicine at the University of Texas, MD Anderson Cancer Center, discusses novel therapeutics for the treatment of multiple myeloma.
In this OncLive video, Jatin J. Shah, MD, assistant professor in lymphoma/myeloma in the Division of Cancer Medicine at the University of Texas, MD Anderson Cancer Center, discusses novel therapeutics for the treatment of multiple myeloma.
Jatin J. Shah, MD, speaks about therapies that have become available in recent years for the treatment of patients with multiple myeloma in this OncLive video. Click here to watch the video and read the article.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa